The global skin boosters market size is expected to reach USD 2.82 billion by 2030, registering a CAGR of 13.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Under this procedure wherein microinjections of biocompatible compounds like hyaluronic acid, vitamins, minerals, and anti-oxidants, etc. that are naturally produced by the body are injected into the epidermis or mesoderm. Also, this simply helps aid in the hydration process, which is fundamental for a youthful glow.
Unlike dermal fillers, skin boosters are not for wrinkle reduction or augmentation, their role is to primarily hydrate the skin and promote the formation of new collagen and elastin to give the skin a firmer appearance. Factors like rising technological advancement in aesthetics, rising disposable income, increasing aesthetic consciousness, and the increasing geriatric population in the search for a natural glow are propelling the market growth. According to Galderma, over five million treatments of Restylane Skinboosters have been performed to date.
The demand is expected to propel significantly due to the fact that it provides a natural glow without distorting facial features or making them appear out of proportion. Growing social media influence, high consciousness towards aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the reasons for market growth.
In the light of COVID-19, the market was hampered as the footfall of patient appointments for surgical treatments was temporarily suspended. However, since the government in many countries has allowed resuming elective aesthetic procedures the demand has been on the rise. Moreover, according to the BBC network, inquiries and appointments for many surgical and non-surgical cosmetic treatments have seen a surge following the pandemic and are thus expected to propel market growth.
Request a free sample copy or view report summary: Skin Boosters Market Report
Mesotherapy led the market and accounted for 54.6% of the global revenue in 2024. Mesotherapy elevates personalization by providing a customized treatment approach to address individual skincare issues.
Hyaluronic acid (HA) skin boosters led the market with a revenue share of 54.9% in 2024. The skin boosters market has witnessed significant growth due to the unique properties and benefits of HA.
The female segment accounted for the largest market revenue share in 2024. This is because women show early signs of aging and dullness majorly due to hormonal fluctuations and related concerns.
Medical spa segment dominated the market in 2024. Skin booster procedures are primarily performed by medspas owing to low patient downtime and non-invasive nature of cosmetic surgery.
North America skin boosters market dominated and accounted for 29.5% share in 2024. The Asia Pacific skin boosters market is anticipated to grow with the fastest CAGR of 14.7% during the forecast period.
Grand View Research has segmented global skin boosters market report based on type, ingredient, gender, end-use, and region:
Skin Boosters Type Outlook (Revenue, USD Million, 2018 - 2030)
Mesotherapy
Micro-needle
Skin Boosters Ingredient Outlook (Revenue, USD Million, 2018 - 2030)
Hyaluronic acid (HA)
Polydeoxyribonucleotides (PDRN)
Poly-L-Lactic Acid (PLLA)/ Poly-D, L-Lactic Acid (PDLLA)
Polycaprolactone (PCL)
Exosomes
Skin Boosters Gender Outlook (Revenue, USD Million, 2018 - 2030)
Female
Male
Skin Boosters End-use Outlook (Revenue, USD Million, 2018 - 2030)
Medspas
Dermatology Clinics
Skin Boosters Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Skin Boosters Market
AbbVie, Inc (Allergen)
Galderma
Sinclair
Merz Pharma
Teoxane
Medytox, Inc.
PharmaResearch Co., Ltd.
VAIM Co., Ltd
Bloomage Biotechnology
IBSA Farmaceutici Italia Srl
Dexlevo Co., Ltd.
LINKUS GLOBAL Co., Ltd.
ExoCoBio Inc.
"The quality of research they have done for us has been excellent..."